Search details
1.
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Blood
; 142(24): 2069-2078, 2023 12 14.
Article
in English
| MEDLINE | ID: mdl-37556734
2.
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Blood
; 142(2): 172-184, 2023 07 13.
Article
in English
| MEDLINE | ID: mdl-37001051
3.
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Blood
; 139(12): 1785-1793, 2022 03 24.
Article
in English
| MEDLINE | ID: mdl-34192312
4.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-35767897
5.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Article
in English
| MEDLINE | ID: mdl-36130297
6.
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature
; 562(7727): 373-379, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30209392
7.
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Pediatr Blood Cancer
; : e30467, 2023 May 31.
Article
in English
| MEDLINE | ID: mdl-37259259
8.
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Cancer
; 128(9): 1863-1870, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35201611
9.
Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.
Blood
; 133(7): 724-729, 2019 02 14.
Article
in English
| MEDLINE | ID: mdl-30510082
10.
Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Blood
; 134(15): 1227-1237, 2019 10 10.
Article
in English
| MEDLINE | ID: mdl-31350265
11.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica
; 106(1): 46-55, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32001530
12.
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(4): e28929, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33559396
13.
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 325(9): 833-842, 2021 03 02.
Article
in English
| MEDLINE | ID: mdl-33651090
14.
The International Consensus Classification of acute leukemias of ambiguous lineage.
Blood
; 141(18): 2275-2277, 2023 05 04.
Article
in English
| MEDLINE | ID: mdl-36877915
15.
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.
Blood
; 131(12): 1350-1359, 2018 03 22.
Article
in English
| MEDLINE | ID: mdl-29284596
16.
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood
; 132(8): 815-824, 2018 08 23.
Article
in English
| MEDLINE | ID: mdl-29997224
17.
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Br J Haematol
; 186(2): 274-285, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30957229
18.
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
Blood
; 129(25): 3352-3361, 2017 06 22.
Article
in English
| MEDLINE | ID: mdl-28408464
19.
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG.
Haematologica
; 104(5): 986-992, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30545921
20.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Pediatr Blood Cancer
; 66(6): e27681, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30848065